Thomas Mandel Clausen

Thomas Mandel Clausen

    Member of:

    • VAR2CSA team

    ORCID: 0000-0001-7543-9622

    Publication year:
    All
    1 - 2 out of 2Page size: 10
    1. 2017
    2. Published

      An oncofetal glycosaminoglycan modification provides therapeutic access to Cisplatin-resistant bladder cancer

      Seiler, R., Oo, H. Z., Tortora, D., Clausen, T. M., Wang, C. K., Kumar, G., Ayres Pereira, M., Ørum-Madsen, M. S., Agerbæk, M. Ø., Gustavsson, T., Nordmaj, M. A., Rich, J. R., Lallous, N., Fazli, L., Lee, S., Douglas, J., Todenhöfer, T., Esfandnia, S., Battsogt, D., Babcook, J. S. & 10 others, Al Nakouzi, N., Crabb, S. J., Moskalev, I., Kiss, B., Davicioni, E., Thalmann, G. N., Rennie, P. S., Black, P. C., Salanti, Ali & Daugaard, M., 2017, In: European Urology Supplements. 72, 1, p. 142-150 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration

      Agerbaek, M. Ø., Bento Ayres Pereira, M. M., Clausen, T. M., Pehrson, C., Oo, H. Z., Spliid, C., Rich, J. R., Fung, V., Nkrumah, F., Neequaye, J., Biggar, R. J., Reynolds, S. J., Tosato, G., Pullarkat, S. T., Ayers, L. W., Theander, T. G., Daugaard, M., Bhatia, K., Nielsen, M. A., Mbulaiteye, S. M. & 1 others, Salanti, Ali, 2017, In: International Journal of Cancer. 140, 7, p. 1597–1608 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 35054027